You should take GLP-1 medicines only with medical guidance, proper dose escalation, diet support, symptom monitoring, and regular health checks
Participants receive medication at no cost during trial participation
PubMed Chroscinska-Krawczyk, M., Ratnaraj, N., Patsalos, P
ABSTRACT Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated considerable efficacy in the treatment of diabetes and obesity, it is essential to recognize that their use is associated with certain intrinsic risks that must not be disregarded
Os eventos adversos foram geralmente leves, transitrios e bem tolerados
Experts : Les mdicaments GLP-1 au-del de la perte de poids Ozempic et Wegovy sont largement utiliss pour favoriser la perte de poids et matriser le diabte